111 related articles for article (PubMed ID: 12668049)
1. Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum.
Cheer JF; Kendall DA; Mason R; Marsden CA
Neuropharmacology; 2003 Apr; 44(5):633-41. PubMed ID: 12668049
[TBL] [Abstract][Full Text] [Related]
2. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study.
Cheer JF; Marsden CA; Kendall DA; Mason R
Neuroscience; 2000; 99(4):661-7. PubMed ID: 10974429
[TBL] [Abstract][Full Text] [Related]
3. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation.
Pistis M; Porcu G; Melis M; Diana M; Gessa GL
Eur J Neurosci; 2001 Jul; 14(1):96-102. PubMed ID: 11488953
[TBL] [Abstract][Full Text] [Related]
4. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
French ED
Neurosci Lett; 1997 May; 226(3):159-62. PubMed ID: 9175591
[TBL] [Abstract][Full Text] [Related]
5. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.
Drew LJ; Harris J; Millns PJ; Kendall DA; Chapman V
Eur J Neurosci; 2000 Jun; 12(6):2079-86. PubMed ID: 10886347
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.
Ralevic V; Kendall DA
Eur J Pharmacol; 2001 Apr; 418(1-2):117-25. PubMed ID: 11334873
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones.
Millns PJ; Chapman V; Kendall DA
Br J Pharmacol; 2001 Mar; 132(5):969-71. PubMed ID: 11226126
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
Wagner JA; Járai Z; Bátkai S; Kunos G
Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptors and reward in the rat: a conditioned place preference study.
Cheer JF; Kendall DA; Marsden CA
Psychopharmacology (Berl); 2000 Jul; 151(1):25-30. PubMed ID: 10958113
[TBL] [Abstract][Full Text] [Related]
10. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice.
DeSanty KP; Dar MS
Pharmacol Biochem Behav; 2001; 69(1-2):251-9. PubMed ID: 11420093
[TBL] [Abstract][Full Text] [Related]
12. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
Robinson L; Goonawardena AV; Pertwee RG; Hampson RE; Riedel G
Br J Pharmacol; 2007 Jul; 151(5):688-700. PubMed ID: 17502849
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids modulate ultrasound-induced aversive responses in rats.
Finn DP; Jhaveri MD; Beckett SR; Kendall DA; Marsden CA; Chapman V
Psychopharmacology (Berl); 2004 Feb; 172(1):41-51. PubMed ID: 14634713
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological study of the response of ventral tegmental area non-dopaminergic neurons to nicotine after concurrent blockade of orexin receptor-2 and cannabinoid receptors-1.
Azizi F; Fartootzadeh R; Alaei H; Reisi P
Brain Res; 2019 Sep; 1719():176-182. PubMed ID: 31153915
[TBL] [Abstract][Full Text] [Related]
15. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Makriyannis A; Hohmann AG
Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
[TBL] [Abstract][Full Text] [Related]
16. Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats.
Chapman V
Neuropharmacology; 2001 Dec; 41(7):870-7. PubMed ID: 11684151
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo.
Perra S; Pillolla G; Melis M; Muntoni AL; Gessa GL; Pistis M
Psychopharmacology (Berl); 2005 Dec; 183(3):368-77. PubMed ID: 16228194
[TBL] [Abstract][Full Text] [Related]
18. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats.
Ellington HC; Cotter MA; Cameron NE; Ross RA
Neuropharmacology; 2002 Jun; 42(7):966-75. PubMed ID: 12069907
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
20. Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging.
Shah YB; Prior MJ; Dixon AL; Morris PG; Marsden CA
Neuropharmacology; 2004 Mar; 46(3):379-87. PubMed ID: 14975693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
